$1.12
1.32% yesterday
Nasdaq, Nov 28, 04:59 pm CET
ISIN
IL0011050551
Symbol
EVGN

Evogene Ltd Stock price

$1.14
-0.14 10.63% 1M
-0.04 2.99% 6M
-0.74 39.30% YTD
-0.49 29.94% 1Y
-5.63 83.21% 3Y
-27.87 96.09% 5Y
-64.87 98.28% 10Y
-25.87 95.80% 20Y
Nasdaq, Closing price Wed, Nov 26 2025
+0.04 3.18%
ISIN
IL0011050551
Symbol
EVGN
Industry

Key metrics

Basic
Market capitalization
$9.9m
Enterprise Value
$10.9m
Net debt
$990.0k
Cash
$11.7m
Shares outstanding
8.7m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
1.5 | 2.1
EV/Sales
1.6 | 2.3
EV/FCF
negative
P/B
negative
Financial Health
Equity Ratio
-3.6%
Return on Equity
1,136.1%
ROCE
-97.7%
ROIC
-93.9%
Debt/Equity
-3.6
Financials (TTM | estimate)
Revenue
$6.6m | $4.7m
EBITDA
$-16.5m | $-11.4m
EBIT
$-18.3m | $-14.0m
Net Income
$-14.3m | $-19.1m
Free Cash Flow
$-18.2m
Growth (TTM | estimate)
Revenue
-29.8% | -44.5%
EBITDA
12.7% | 40.4%
EBIT
14.8% | 35.2%
Net Income
28.2% | -15.8%
Free Cash Flow
12.1%
Margin (TTM | estimate)
Gross
47.4%
EBITDA
-248.6% | -242.5%
EBIT
-276.0%
Net
-214.9% | -404.6%
Free Cash Flow
-274.3%
More
EPS
$-2.0
FCF per Share
$-2.1
Short interest
1.1%
Employees
117
Rev per Employee
$70.0k
Show more

Is Evogene Ltd a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,070 stocks worldwide.

Evogene Ltd Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Evogene Ltd forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a Evogene Ltd forecast:

Buy
86%
Hold
14%

Financial data from Evogene Ltd

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
6.63 6.63
30% 30%
100%
- Direct Costs 3.49 3.49
98% 98%
53%
3.15 3.15
59% 59%
48%
- Selling and Administrative Expenses 8.83 8.83
9% 9%
133%
- Research and Development Expense 13 13
35% 35%
190%
-16 -16
13% 13%
-249%
- Depreciation and Amortization 1.82 1.82
30% 30%
27%
EBIT (Operating Income) EBIT -18 -18
15% 15%
-276%
Net Profit -14 -14
28% 28%
-215%

In millions USD.

Don't miss a Thing! We will send you all news about Evogene Ltd directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Evogene Ltd Stock News

Neutral
Seeking Alpha
7 days ago
EverGen Infrastructure Corp. ( EVGN:CA ) Q3 2025 Earnings Call November 21, 2025 11:00 AM EST Company Participants Chase Edgelow - CEO & Director Maria O'Sullivan - Interim Chief Financial Officer Presentation Operator Welcome to the EverGen Infrastructure Third Quarter 2025 earnings results presentation. [Operator Instructions] As a reminder, this call is being recorded.
Neutral
Seeking Alpha
8 days ago
Evogene Ltd. ( EVGN ) Q3 2025 Earnings Call November 20, 2025 9:00 AM EST Company Participants Ofer Haviv - CEO, President & Director Yaron Eldad - Chief Financial Officer Presentation Operator Welcome to Evogene's Third Quarter 2025 Results Conference Call.
Neutral
PRNewsWire
8 days ago
Conference call and webcast: today, November 20, 2025, 9:00 AM ET Financial Highlights: During the first nine months ending September 30, 2025, Evogene advanced its strategic transition toward establishing itself as a leader in computational chemistry, with a focus on the generative design of small molecules for the pharmaceutical and agricultural industries. As part of this new strategy, the c...
More Evogene Ltd News

Company Profile

Evogene Ltd. operates as a plant genomics company. It utilizes a proprietary integrated technology infrastructure to enhance seed traits underlying crop productivity. It also offers a solution for crop productivity improvement through biotechnology and breeding using a technology infrastructure that is based on deep scientific understanding of plant genomics and proprietary computational capabilities. The company was founded by Amir Barzilay and Hagai Karchi in 2002 and is headquartered in Rehovot, Israel.

Head office Israel
CEO Ofer Haviv
Employees 117
Founded 1999
Website evogene.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today